RxDoctor Payments Data

Robert Funk, MD

Pain Medicine · Carmel, INNPI 1316265457

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Zimmer Biomet at 46.2% of the total. Reporting peaked in 2019 at $3,016 and has fallen 80.5% since, to $589 in 2025.

$9,376in general payments, 2019–2025

Across 216 payments — averaging $43.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$4K
  • Abbott$3K
  • Saluda Medical Americas, Inc.$460
  • Stryker$413
  • Relievant Medsystems, Inc.$300
  • Medtronic$278
  • plus $375 from 7 others
$407,458in research payments, 2019–2025

Across 72 payments — averaging $5659.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$407K

What the payments were for

  • Travel & lodging$2463%
  • Food & beverage$4,79751%
  • Education$4,33346%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,376 in reported general payments places this provider in the 75th percentile of 128 pain medicine providers in Indiana.

See all pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$177,946
Medicare patients
324
Services billed
4,890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine16$1,548
Celecoxib11$1,244
Pregabalin32$939
Gabapentin127$906
Diclofenac Sodium81$803
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$500
Cyclobenzaprine Hcl61$295
Tramadol Hcl53$252
Methylprednisolone33$163
Diazepam26$18
Meloxicam14$15

Paid to pharmacies, not to this prescriber.

Other pain medicine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →